Cited by 126Syphilis Diagnosis and TreatmentVector-borne infectious diseasesReproductive tract infections research

Molecular and direct detection tests for Treponema pallidum subspecies pallidum: a review of the literature, 1964–2017.

Open access
Theel, Elitza S, Katz, Samantha S, Pillay, Allan·2020·Clinical Infectious Diseases

Abstract

Direct detection methods for Treponema pallidum include dark-field microscopy (DFM), direct fluorescence antibody (DFA) testing, immunohistochemistry (IHC), and nucleic acid amplification tests (NAATs). Here, we reviewed the relevant syphilis diagnostic literature to address 2 main questions with respect to T. pallidum direct detection techniques: "What are the performance characteristics for each direct detection test for T. pallidum and what are the optimal specimen types for each test?" and "What options are available for T. pallidum molecular epidemiology?" To answer these questions, we searched 5 electronic databases (OVID Medline, OVID Embase, CINAHL, Cochrane Library, and Scopus) from 1964 to 2017 using relevant search terms and identified 1928 articles, of which 37 met our inclusion criteria. DFM and DFA sensitivities ranged from 73% to 100% in cases of primary syphilis; and while sensitivity using silver stain histopathology for T. pallidum was generally low (0%-41%), higher performance characteristics were observed for T. pallidum-specific IHC (49-92%). Different genes have been targeted by T. pallidum-specific NAATs, with the majority of studies indicating that sensitivity is primarily dependent on the type of collected biological sample, with highest sensitivity observed in primary lesion exudate (75-95%). Given the rising incidence of syphilis, the development of direct, Food and Drug Administration-cleared T. pallidum NAATs should be considered an immediate priority.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cid/ciaa176

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Direct fluorescence antibody (DFA-TP) reagents are unavailable.

    “direct fluorescence antibody (DFA-TP) reagents are unavailable (565).”

    From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [565]

    The Results and Discussion section describes limited accessibility of DFA reagents, which supports a concern about availability. It does not say they are unavailable: it states that the antibodies may be commercially available, although none are FDA-cleared for clinical laboratory use. Page numbers were not provided in our copy. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [36]Gayet-Ageron A, Sednaoui P, Lautenschlager S, et al. Use of Treponema pallidum PCR in testing of ulcers for diagnosis of primary syphilis. Emerg Infect Dis 2015; 21: 127– 9. 25531672 PMC4285282
  2. [53]Tipple C, McClure MO, Taylor GP High prevalence of macrolide resistant Treponema pallidum strains in a London centre. Sex Transm Infect 2011; 87: 486– 8. 21917695

Cited by

Sorted by citations

Authors
Theel, E. S., Katz, S. S., & Pillay, A.
Affiliations
  • Mayo Clinic (US)
  • Centers for Disease Control and Prevention (US)
Corresponding author
Theel, Elitza S
Venue
Clinical Infectious Diseases
Published
2020-06-24
Volume
71
Issue
Supplement_1
Pages
S4-S12
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W3037303032
Cited by
126
References
52
Citations by year
2026: 16 · 2025: 22 · 2024: 24 · 2023: 28 · 2022: 21 · 2021: 13 · 2020: 2
FWCI
2.04
Type
journal article
Language
en
Open access
Locations
  • Clinical Infectious Diseases (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Syphilis Diagnosis and Treatment
  • Life Sciences › Immunology and Microbiology › Parasitology › Vector-borne infectious diseases
  • Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
Keywords
Treponema pallidum, syphilis diagnosis, dark-field microscopy, immunohistochemistry, nucleic acid amplification tests, molecular epidemiology, diagnostic sensitivity, specimen type, primary syphilis
MeSH terms
Globus Pallidus, Humans, Microscopy, Syphilis, Treponema pallidum, Molecular Epidemiology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review